CareFusion strengthens ventilator offering with ResMed US distribution deal
This article was originally published in Clinica
Executive Summary
CareFusion has gained exclusive rights to distribute ResMed's Stellar 100 and 150 noninvasive ventilators (NIVs) in the US, giving it a more competitive portfolio in the institutional NIV market. The companies estimate that the segment is growing by more than 6% per year, driven by an increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD).